| 1 |
33832852 | Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer. | 2021 Oct |
1 |
| 2 |
30554488 | Correlation of UGT2B7 Polymorphism with Cardiotoxicity in Breast Cancer Patients Undergoing Epirubicin/Cyclophosphamide-Docetaxel Adjuvant Chemotherapy. | 2019 Jan |
3 |
| 3 |
26452313 | A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer. | 2016 Apr |
6 |
| 4 |
27474751 | Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines. | 2016 Oct |
1 |
| 5 |
25713207 | Induction of human UDP-Glucuronosyltransferase 2B7 gene expression by cytotoxic anticancer drugs in liver cancer HepG2 cells. | 2015 May |
4 |
| 6 |
23110092 | Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells. | 2012 |
2 |
| 7 |
21658222 | Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer. | 2011 Jun 9 |
6 |
| 8 |
16985101 | Epirubicin glucuronidation and UGT2B7 developmental expression. | 2006 Dec |
1 |
| 9 |
11302935 | Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. | 2001 May |
5 |